MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suwanmanee, T.
Right arrow Articles by Kole, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suwanmanee, T.
Right arrow Articles by Kole, R.

Vol. 62, Issue 3, 545-553, September 2002

Restoration of Human beta -Globin Gene Expression in Murine and Human IVS2-654 Thalassemic Erythroid Cells by Free Uptake of Antisense Oligonucleotides

Thipparat Suwanmanee, Halina Sierakowska, Giuseppina Lacerra, Saovaros Svasti, Suzanne Kirby, Christopher E. Walsh, Suthat Fucharoen, and Ryszard Kole

Lineberger Comprehensive Cancer Center (T.S., H.S., G.L., S.S., R.K., S.K.), Departments of Pharmacology (T.S., H.S., G.L., S.S., R.K.), Pathology (S.K.), Medicine (S.K., C.E.W.), and Gene Therapy Center (C.E.W.), University of North Carolina, Chapel Hill, North Carolina; and Thalassemia Research Center, Institute of Science and Technology for Research and Development, Mahidol University, Salaya Campus, Nakornpathom, Thailand (S.F.)

Correct human beta -globin mRNA has been restored in erythroid cells from transgenic mice carrying the human gene with beta -globin IVS2-654 splice mutation and from thalassemia patients with the IVS2-654/beta E genotype. This was accomplished in a dose- and time-dependent manner by free uptake of morpholino oligonucleotide antisense to the aberrant splice site at position 652 of intron 2 in beta -globin pre-mRNA. Under optimal conditions of oligonucleotide uptake, the maximal levels of correct human beta -globin mRNA and hemoglobin A in patients' erythroid cells were 77 and 54%, respectively. These levels of correction were equal to, if not higher than, those obtained by syringe loading of the oligonucleotide into the cells. Comparison of splicing correction results with the cellular uptake of fluorescein-labeled oligonucleotide indicated that the levels of mRNA and hemoglobin A correlate well with the nuclear localization of the oligonucleotide and the degree of erythroid differentiation of cultured cells. Similar but not as pronounced results were obtained after the oligonucleotide treatment of bone marrow cells from IVS2-654 mouse. The effectiveness of the free antisense morpholino oligonucleotide in restoration of correct splicing of IVS2-654 pre-mRNA in cultured erythropoietic cells from transgenic mice and thalassemic patients suggests the applicability of this or similar compounds in in vivo experiments and possibly in treatment of thalassemia.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Svasti, T. Suwanmanee, S. Fucharoen, H. M. Moulton, M. H. Nelson, N. Maeda, O. Smithies, and R. Kole
RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
PNAS, January 27, 2009; 106(4): 1205 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Du, J. M. Pollard, and R. A. Gatti
Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides
PNAS, April 3, 2007; 104(14): 6007 - 6012.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. S. Mattick and I. V. Makunin
Small regulatory RNAs in mammals
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R121 - R132.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
I. G. Bruno, W. Jin, and G. J. Cote
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements
Hum. Mol. Genet., October 1, 2004; 13(20): 2409 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. Ittig, S. Liu, D. Renneberg, D. Schumperli, and C. J. Leumann
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA
Nucleic Acids Res., January 15, 2004; 32(1): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. L. Gebski, C. J. Mann, S. Fletcher, and S. D. Wilton
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle
Hum. Mol. Genet., August 1, 2003; 12(15): 1801 - 1811.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. M. Vacek, H. Ma, F. Gemignani, G. Lacerra, T. Kafri, and R. Kole
High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA
Blood, January 1, 2003; 101(1): 104 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Gemignani, P. Sazani, P. Morcos, and R. Kole
Temperature-dependent splicing of {beta}-globin pre-mRNA
Nucleic Acids Res., November 1, 2002; 30(21): 4592 - 4598.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics